Horizon Pharma plc Presents Data on KRYSTEXXA (pegloticase) for the Management of Refractory Chronic...
Horizon Pharma plc Presents Data on KRYSTEXXA (pegloticase) for the Management of Refractory Chronic Gout at the 2016 ACR/ARHP Annual Meeting
About this item
Full title
Publisher
Melbourne: News Bites Pty Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Melbourne: News Bites Pty Ltd
Subjects
More information
Alternative Titles
Full title
Horizon Pharma plc Presents Data on KRYSTEXXA (pegloticase) for the Management of Refractory Chronic Gout at the 2016 ACR/ARHP Annual Meeting
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1838744267
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1838744267